Claudine Bruck, Director at Annovis Bio, Inc. (ANVS), bought 181 shares at $27.66 ($5K) on 2021-10-11, disclosed to the SEC on 2021-10-13.
Open-market purchase of $5k ANVS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |